Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis
Authors:
- 16 November 2016
- journal article
- review article
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 17 (11) , 831-841
Abstract
Liver fibrosis is the end-stage of many chronic liver diseases and is a significant health threat. The only effective therapy is liver transplantation, whiKeywords
Funding Information
- e National High-Tech R & D Program (863) of China (2015AA020306)
This publication has 82 references indexed in Scilit:
- Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cellsJournal of Zhejiang University-SCIENCE B, 2013
- Genome Engineering ofDrosophilawith the CRISPR RNA-Guided Cas9 NucleaseGenetics, 2013
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- Immunomodulatory properties and therapeutic application of mesenchymal stem cellsClinical and Experimental Immunology, 2011
- Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model†Hepatology, 2009
- Native Umbilical Cord Matrix Stem Cells Express Hepatic Markers and Differentiate Into Hepatocyte-like CellsGastroenterology, 2008
- Immunomodulation of activated hepatic stellate cells by mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrowBMC Developmental Biology, 2007
- The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create itDevelopmental Dynamics, 2005